Navigation Links
Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years

New study results also show evidence of additional protection against infection with other cancer-causing virus types

LOS ANGELES, April 17, 2007 /PRNewswire-FirstCall/ -- The GlaxoSmithKline cervical cancer candidate vaccine, CERVARIX(R), demonstrated 100 percent efficacy in preventing precancerous lesions due to cancer-causing human papillomavirus types 16 and 18 for up to 5.5 years in an extended follow-up trial, according to data presented today at the American Association for Cancer Research. The trial results demonstrate the longest duration of protection seen in any cervical cancer vaccine trial reported to date.

The GSK cervical cancer candidate vaccine also showed 68 percent vaccine efficacy against precancerous lesions (CIN2+) and 38 percent vaccine efficacy against abnormal Pap smears, regardless of the type of cancer-causing virus detected. These results suggest evidence of protection beyond what might be expected from a vaccine that is designed to target virus types 16 and 18 alone. More specifically, the study confirmed that the candidate vaccine provides further preliminary evidence of cross-protection against incident infection with cancer-causing virus types 45 and 31 that also extended up to 5.5 years after vaccination.

"These new data from this extended follow-up trial are exciting for those of us who are working to prevent cervical cancer, and for women around the world," said Dr. Stanley Gall, lead investigator and Professor of Obstetrics, Gynecology and Women's Health at the University of Louisville, Kentucky. "Demonstrating 100 percent efficacy and sustained immune response for more than five years is a significant contribution to the scientific understanding of preventing cervical cancer and precancerous lesions through vaccination."

Additionally, the trial found that the candidate vaccine induced a strong immune response in virtually 100 percent of women in the stud
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
2. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
5. Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia
6. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
Post Your Comments:
(Date:12/1/2008)...icy , , ROCHESTER, Minn., Dec. 1 /PRNewswi...ds the use of the drug therapy etanercept ineffect...ammation of the liver caused by excessive consumpt...shed in the December issue of Gastroenterology (...O ALERT: Additional audio and video resources, inc...
(Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...
(Date:11/30/2008)...e-USNewswire/ -- Older adults who exercise regular...r number of small blood vessels in the brain, acco...eting of the Radiological Society of North America...University of North Carolina ( UNC) - Chapel Hill...ults who exercise to brain scans of those who do n...
(Date:11/28/2008)...tCall/ -- Eli Lilly and Company,(NYSE: LLY ) ha...(sNDA) from,the U.S. Food and Drug Administration...anagement of chronic pain. Lilly plans to resubmit...g data from a recently completed positive study,i... The decision does not affect duloxetine,s FDA-ap...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Barr Announces Approval of Generic Yasmin 28R 29 5282 1Barr Announces Approval of Generic Yasmin 28R 29 5282 2Barr Announces Approval of Generic Yasmin 28R 29 5282 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 1New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 5New Class of Drugs Might Treat Many Conditions 18938 1New Class of Drugs Might Treat Many Conditions 18938 2Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 1Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 2Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 3
...e Skeletal Muscle More,Efficiently than Male Cells...e stem cells,derived from muscle have a greater ab...le cells, according to a study at Children,s,Hospi...eing published in the April 9 issue of the,Journal...fference,in regenerative capabilities of muscle st...
...007 - Inotek,Pharmaceuticals Corporation announced...eclinical animal data showing that the,administrat...tor,has a large protective effect on the survival ... a nuclear enzyme that directs the,repair of damag...epair enzymes and has potential applications for t...
Other Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3
(Date:12/2/2008)...unces integration of its,HealthURL Appliance with...are,Organizations. The EMC Open Systems Archive S...odular DICOM-compliant management platform that,a...uding medical images from,clinical and business a...ntegration with the MedCommons appliance unifies t...
(Date:12/2/2008)...onse Biomedical Corporation (TSX: RBM, OTCBB: RPBI... the Company,s RAMP(R) test to detect Respiratory ...linical study is expected to be used to support a ...n (FDA) and other regulatory jurisdictions for mar...or clinical use. The study is designed to demonstr...
(Date:12/2/2008)...Over Next Decade, According to a New Report from D...2 Decision Resources, one of the w...rmaceutical and healthcare issues, finds that the ...ust growth in the United States over the next deca...e new special report entitled Cellular Therapies,...
(Date:12/2/2008)...l/ -- China Sky One Medical,Inc. ("China Sky One...eading,fully integrated pharmaceutical company pr...public of China ("PRC"), announced today that Mr. ... Officer and Secretary and will,also serve on the... Zhang, who,had served as interim CFO since June,...
Breaking Medicine News(10 mins):Health News:MedCommons HealthURL, a New Unified Clinical Viewer Appliance, Is Integrated with EMC Open Systems Archive Solution for Healthcare Organizations 2Health News:MedCommons HealthURL, a New Unified Clinical Viewer Appliance, Is Integrated with EMC Open Systems Archive Solution for Healthcare Organizations 3Health News:Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial 2Health News:Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial 3Health News:Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial 4Health News:Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 3
... cancer survivors can halve the risk of dying from...se moderately regardless of their weight, suggest...er at the University of California, San Diego (UCS...nical Oncology, this is the first study to look at...
...chers at USC and Caltech have spectacularly slowed...ows general promise in pharmaceutical development ...ut how to make the fruit fly live longer. But the...have something for humans. As reported online in N...
...te Cancer is the most frequently diagnosed cancer ...th prostate cancer this year alone, and more than ...s Month, and with Fathers Day approaching, its a g... prostates healthy and be proactive about cancer p...
...ate department of Health today confirmed the death... virus. This is the first case in 2007 and it see... record number 177 people died due to the virus. ...West Nile this year, while no other state has had ...
Other Medicine News:Health News:Healthy Diet, Exercise can Halve the Risk of Mortality in Breast Cancer Survivors 2Health News:Super Fruit Fly may Harbor Hope for Human Longevity 2Health News:Tips to Maintain a Healthy Prostate 2Health News:First Case of West Nile Virus Death in Madison County 2
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Small, comes in a compact carrying case, carrying pouch included.
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure.
Medicine Products: